Cholera toxin adjuvant promotes a balanced Th1/Th2/Th17 response independently of IL-12 and IL-17 by acting on Gsα in CD11b + DCs

Mucosal Immunology

Volumn 8, Issue 4, 2015, Pages 815-827

  Mattsson, J ^a   Schon K ^a   Ekman, L ^a   Fahlen Yrlid L ^a   Yrlid, U ^a   Lycke, N Y ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CELL PROTEIN; CHOLERA TOXIN; GS ALPHA PROTEIN; IMMUNOGLOBULIN A; INTERLEUKIN 12; INTERLEUKIN 17; UNCLASSIFIED DRUG; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CD4+ T LYMPHOCYTE; CELL MATURATION; CELL SUBPOPULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TH1 CELL; TH17 CELL; TH2 CELL; WILD TYPE; ANIMAL; GENE EXPRESSION; GENETICS; HELPER CELL; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; T LYMPHOCYTE SUBPOPULATION; TIME FACTOR;

ANIMALS; ANTIGENS, CD11B; CHOLERA TOXIN; DENDRITIC CELLS; GENE EXPRESSION; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; IMMUNIZATION; INTERLEUKIN-12; INTERLEUKIN-17; MICE; MICE, KNOCKOUT; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS; TH17 CELLS; TH2 CELLS; TIME FACTORS;

EID: 84932598662     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2014.111     Document Type: Article

References (68)

1. Lycke N. Recent progress in mucosal vaccine development: potential and limitations. Na.t Rev. Immunol. 12, 592-605 (2012
2. Mattsson J. & Lycke N.Y. Bacterial enterotoxins as immunomodulators and vaccine adjuvants. In Bacterial Toxins: Genetics, Cellular Biology and Practical Applications (Proft T., ed) 93-114 (Caister Academic Press, Norfolk, UK, 2013
3. Lavelle E.C., et al. Effects of cholera toxin on innate and adaptive immunity and its application as an immunomodulatory agent. J. Leukoc. Biol. 75, 756-763 (2004
4. Holmgren J. & Czerkinsky C. Mucosal immunity and vaccines. Nat. Med. 11 (4 Suppl), S45-S53 (2005
5. Freytag L.C. & Clements J.D.Mucosal adjuvants. Vaccine 23, 1804-1813 (2005
6. Rappuoli R., Pizza M., Douce G. & Dougan G. Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins. Immunol. Today 20, 493-500 (1999
7. Pizza M., et al. Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants. Vaccine 19, 2534-2541 (2001
8. Freytag L.C., Clements J.D., Grdic Eliasson D. & Lycke N.Y. Use of genetically or chemically detoxified mutants of Cholera and Escherichia coli heat-labile enterotoxins asmucosal adjuvants. In New Generation Vaccines (Levine M.M., ed) 273-283 (Informa Healthcare, New York, 2010
9. Gustafsson T., Hua Y.J., Dahlgren M.W., Livingston M., Johansson- Lindbom B. & Yrlid U. Direct interaction between cholera toxin and dendritic cells is required for oral adjuvant activity. Eur. J. Immunol. 43, 1779-1788 (2013
10. Fahlen-Yrlid L., et al. CD11c(high )dendritic cells are essential for activation of CD4+ T cells and generation of specific antibodies following mucosal immunization. J. Immunol. 183, 5032-5041 (2009
11. Lavelle E.C., McNeela E., Armstrong M.E., Leavy O., Higgins S.C. & Mills K.H. Cholera toxin promotes the induction of regulatory T cells specific for bystander antigens by modulating dendritic cell activation. J. Immunol. 171, 2384-2392 (2003
12. Grdic D., et al. Splenic marginal zone dendritic cells mediate the cholera toxin adjuvant effect: dependence on the ADP-ribosyltransferase activity of the holotoxin. J. Immunol. 175, 5192-5202 (2005
13. Anjuere F., et al. In vivo adjuvant-induced mobilization and maturation of gut dendritic cells after oral administration of cholera toxin. J. Immunol. 173, 5103-5111 (2004
14. Olvera-Gomez I., et al. Cholera toxin activates nonconventional adjuvant pathways that induce protective CD8 T-cell responses after epicutaneous vaccination. Proc. Natl. Acad. Sci. USA 109, 2072-2077 (2012
15. Song J.H., et al. CCR7-CCL19/CCL21-regulated dendritic cells are responsible for effectiveness of sublingual vaccination. J. Immunol. 182, 6851-6860 (2009
16. Lee A.Y., et al. Dendritic cells in colonic patches and iliac lymph nodes are essential in mucosal IgA induction following intrarectal administration via CCR7 interaction. Eur. J. Immunol. 38, 1127-1137 (2008
17. Blazquez A.B. & Berin M.C. Gastrointestinal dendritic cells promote Th2 skewing via OX40L. J. Immunol. 180, 4441-4450 (2008
18. Marinaro M., et al. Mucosal adjuvant effect of cholera toxin inmice results from inductionofThelper2(Th2) cells andIL-4. J. Immunol.155, 4621-4629(1995
19. Xu-Amano J., Jackson R.J., Fujihashi K., Kiyono H., Staats H.F. & McGhee J.R. Helper Th1 and Th2 cell responses following mucosal or systemic immunization with cholera toxin. Vaccine 12, 903-911 (1994
20. Hornquist E. & Lycke N. Cholera toxin adjuvant greatly promotes antigen priming of T cells. Eur. J. Immunol. 23, 2136-2143 (1993
21. Jones H.P., Hodge L.M., Fujihashi K., Kiyono H., McGhee J.R. & Simecka J.W. The pulmonary environment promotes Th2 cell responses after nasal-pulmonary immunization with antigen alone, but Th1 responses are induced during instances of intense immune stimulation. J. Immunol. 167, 4518-4526 (2001
22. Meza-Sanchez D., Perez-Montesinos G., Sanchez-Garcia J., Moreno J. & Bonifaz L.C. Intradermal immunization in the ear with cholera toxin and its non-toxic beta subunit promotes efficient Th1 and Th17 differentiation dependent on migrating DCs. Eur. J. Immunol. 41, 2894-2904 (2011
23. la Sala A., et al. Cholera toxin inhibits IL-12 production and CD8alpha+ dendritic cell differentiation by cAMP-mediated inhibition of IRF8 function. J. Exp. Med. 206, 1227-1235 (2009
24. Braun M.C., He J., Wu C.Y. & Kelsall B.L. Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor beta1 and beta2 chain expression. J. Exp. Med. 189, 541-552 (1999
25. Li X., et al. Divergent requirement for Galphas and cAMP in the differentiation and inflammatory profile of distinct mouse Th subsets. J. Clin. Invest. 122, 963-973 (2012
26. Yao C., Hirata T., Soontrapa K., Ma X., Takemori H. & Narumiya S. ProstaglandinE(2)promotesTh1 differentiation via synergistic amplificationof IL-12 signalling by cAMP and PI3-kinase. Nat. Commun. 4, 1685 (2013
27. Hervouet C., et al. Langerhans cells prime IL-17-producing T cells and dampen genital cytotoxic responses following mucosal immunization. J. Immunol. 184, 4842-4851 (2010
28. Lee J.B., Jang J.E., Song M.K. & Chang J. Intranasal delivery of cholera toxin induces th17-dominated T-cell response to bystander antigens. PLoS One 4, e5190 (2009
29. Datta S.K., et al. Mucosal adjuvant activity of cholera toxin requires Th17 cells and protects against inhalation anthrax. Proc. Natl. Acad. Sci. USA 107, 10638-10643 (2010
30. Hirota K., et al. Plasticity of Th17 cells in Peyer's patches is responsible for the induction of T cell-dependent IgA responses. Nat. Immunol. 14, 372-379 (2013
31. Agren L.C., Ekman L., Lowenadler B., Nedrud J.G. & Lycke N.Y. Adjuvanticity of the cholera toxin A1-based gene fusion protein, CTA1-DD, is critically dependent on the ADP-ribosyltransferase and Ig-binding activity. J. Immunol. 162, 2432-2440 (1999
32. Gustafsson T., Hua Y.-J., Dahlgren M., Livingston M., Johansson- Lindbom B. & Yrlid U. Direct interaction between cholera toxin and dendritic cells is required for oral adjuvant activity. Eur. J. Immunol. 43, 1779-1788 (2013
33. Eriksson K., Fredriksson M., Nordstrom I. & Holmgren J. Cholera toxin and itsBsubunit promote dendritic cell vaccinationwith different influences on Th1 and Th2 development. Infect. Immun. 71, 1740-1747 (2003
34. Cua D.J., et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421, 744-748 (2003
35. Ghilardi N., Kljavin N., Chen Q., Lucas S., Gurney A.L. & De Sauvage F.J. Compromised humoral and delayed-type hypersensitivity responses in IL-23-deficient mice. J. Immunol. 172, 2827-2833 (2004
36. Lighvani A.A., et al. T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells. Proc. Natl. Acad. Sci. USA 98, 15137-15142 (2001
37. Thierfelder W.E., et al. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382, 171-174 (1996
38. Hildner K., et al. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic Tcell immunity. Science 322, 1097-1100 (2008
39. Agren L.C., Ekman L., Lowenadler B. & Lycke N.Y. Genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit. J. Immunol. 158, 3936-3946 (1997
40. Caton M.L., Smith-Raska M.R. & Reizis B. Notch-RBP-J signaling controls the homeostasis of CD8- dendritic cells in the spleen. J. Exp. Med. 204, 1653-1664 (2007
41. Weinstein L.S., Xie T., Zhang Q.H. & Chen M. Studies of the regulation and function of the Gs alpha gene Gnas using gene targeting technology. Pharmacol. Ther. 115, 271-291 (2007
42. Kahn R.A. & Gilman A.G. ADP-ribosylation of Gs promotes the dissociation of its alpha and beta subunits. J. Biol. Chem. 259, 6235-6240 (1984
43. Kassis S., Hagmann J., Fishman P.H., Chang P.P. & Moss J. Mechanism of action of cholera toxin on intact cells. Generation of A1 peptide and activation of adenylate cyclase. J. Biol. Chem. 257, 12148-12152 (1982
44. Gagliardi M.C., Sallusto F., Marinaro M., Langenkamp A., Lanzavecchia A. & De Magistris M.T. Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming. Eur. J. Immunol. 30, 2394-2403 (2000
45. Procopio D.O., et al. Differential inhibitory mechanism of cyclic AMP on TNF-alpha and IL-12 synthesis by macrophages exposed to microbial stimuli. Br. J. Pharmacol. 127, 1195-1205 (1999
46. Takeda K., et al. Defective NK cell activity and Th1 response in IL-18- deficient mice. Immunity 8, 383-390 (1998
47. Yoshida H., et al. WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity 15, 569-578 (2001
48. Cousens L.P., et al. Two roads diverged: interferon alpha/beta- and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection. J. Exp. Med. 189, 1315-1328 (1999
49. Minter L.M., et al. Inhibitors of gamma-secretase block in vivo and in vitro T helper type 1 polarization by preventing Notch upregulation of Tbx21. Nat. Immunol. 6, 680-688 (2005
50. Yoshimoto T., et al. IL-12 up-regulates IL-18 receptor expression on Tcells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. J. Immunol. 161, 3400-3407 (1998
51. Takeda A., et al. Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J. Immunol. 170, 4886-4890 (2003
52. Freudenberg M.A., Merlin T., Kalis C., Chvatchko Y., Stubig H. & Galanos C. Cutting edge: a murine, IL-12-independent pathway of IFNgamma induction by gram-negative bacteria based on STAT4 activation by Type I IFN and IL-18 signaling. J. Immunol. 169, 1665-1668 (2002
53. Akhiani A.A., Schon K. & Lycke N. Vaccine-induced immunity against Helicobacter pylori infection is impaired in IL-18-deficient mice. J. Immunol. 173, 3348-3356 (2004
54. Amsen D., Blander J.M., Lee G.R., Tanigaki K., Honjo T. & Flavell R.A. Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell 117, 515-526 (2004
55. Skokos D. & Nussenzweig M.C. CD8- DCs induce IL-12-independent Th1 differentiation through Delta 4 Notch-like ligand in response to bacterial LPS. J. Exp. Med. 204, 1525-1531 (2007
56. Bromander A., Holmgren J. & Lycke N. Cholera toxin stimulates IL-1 production and enhances antigen presentation by macrophages in vitro. J. Immunol. 146, 2908-2914 (1991
57. Seo G.Y., Youn J. & Kim P.H. IL-21 ensures TGF-beta 1-induced IgA isotype expression in mouse Peyer's patches. J. Leukoc. Biol. 85, 744-750 (2009
58. Ruedl C. & Hubele S. Maturation of Peyer's patch dendritic cells in vitro upon stimulation via cytokines or CD40 triggering. Eur. J. Immunol. 27, 1325-1330 (1997
59. Kampgen E., et al. Class II major histocompatibility complex molecules of murine dendritic cells: synthesis, sialylation of invariant chain, and antigen processing capacity are down-regulated upon culture. Proc. Natl. Acad. Sci. USA 88, 3014-3018 (1991
60. Sjoblom-Hallen A., et al. Gene expression profiling identifies STAT3 as a novel pathway for immunomodulation by cholera toxin adjuvant. Mucosal. Immunol. 3, 374-386 (2010
61. Shreedhar V.K., Kelsall B.L. & Neutra M.R. Cholera toxin induces migration of dendritic cells from the subepithelial dome region to T- and B-cell areas of Peyer's patches. Infect. Immun. 71, 504-509 (2003
62. Porgador A., Staats H.F., Itoh Y. & Kelsall B.L. Intranasal immunization with cytotoxic T-lymphocyte epitope peptide and mucosal adjuvant cholera toxin: selective augmentation of peptide-presenting dendritic cells in nasal mucosa-associated lymphoid tissue. Infect. Immun. 66, 5876-5881 (1998
63. Kawamura Y.I., et al. Cholera toxin activates dendritic cells through dependence on GM1-ganglioside which is mediated by NF-kappaB translocation. Eur. J. Immunol. 33, 3205-3212 (2003
64. Cong Y., Weaver C.T. & Elson C.O. The mucosal adjuvanticity of cholera toxin involves enhancement of costimulatory activity by selective upregulation of B7.2 expression. J. Immunol. 159, 5301-5308 (1997
65. Schwickert T.A., et al. In vivo imaging of germinal centres reveals a dynamic open structure. Nature 446, 83-87 (2007
66. Shih T.A., Roederer M. & Nussenzweig M.C. Role of antigen receptor affinity in T cell-independent antibody responses in vivo. Nat. Immunol. 3, 399-406 (2002
67. Nakae S., et al. Antigen-specific T cell sensitization is impaired in IL-17- deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17, 375-387 (2002
68. Mueller C.G., et al. Mannose receptor ligand-positive cells express the metalloprotease decysin in the B cell follicle. J. Immunol. 167, 5052-5060 (2001